Autoimmune (AA) amyloidosis/Secondary

AA Amyloidosis: Pathogenesis and Targeted Therapy

AA amyloidosis was previously known as secondary amyloidosis, or reactive systemic amyloidosis. It occurs in patients who have suffered from prolonged, chronic…

AA Amyloidosis Treated With Tocilizumab: Case Series and Updated Literature Review

Subscribe to

RNAi Explained

Dr. Bersell explores RNA interference (RNAi) technology and its applications in treating ATTR-CM and ATTR-PN. Learn about mechanism of action, clinical evidence, and patient outcomes.

Learn More

Expert Perspectives on Attruby®

Dr. Barry Trachtenberg and ATTR community members discuss Attruby™ (acoramidis), covering clinical data, patient perspectives, and treatment considerations.

Watch Discussion